These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10835763)

  • 21. Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock.
    Zhou SX; Qiu HB; Huang YZ; Yang Y; Zheng RQ
    Acta Pharmacol Sin; 2002 Jul; 23(7):654-8. PubMed ID: 12100762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum level of cardiac troponin I in pediatric patients with sepsis or septic shock.
    Oliveira NS; Silva VR; Castelo JS; Elias-Neto J; Pereira FE; Carvalho WB
    Pediatr Crit Care Med; 2008 Jul; 9(4):414-7. PubMed ID: 18843251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blue dye, green heart.
    Tan CD; Rodriguez ER
    Cardiovasc Pathol; 2010; 19(2):125-6. PubMed ID: 18703358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of hydrocortisone on phenylephrine--mean arterial pressure dose-response relationship in septic shock.
    Bellissant E; Annane D
    Clin Pharmacol Ther; 2000 Sep; 68(3):293-303. PubMed ID: 11014411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-adrenergic inotropic support in septic shock.
    Domb M; De Boelpaepe C; Vincent JL
    Prog Clin Biol Res; 1987; 236B():319-22. PubMed ID: 3615476
    [No Abstract]   [Full Text] [Related]  

  • 26. Once is enough: limited echocardiography in subacute shock.
    Kanji HD; Sirounis D; Boyd JH
    J Crit Care; 2015 Apr; 30(2):431-2. PubMed ID: 25579374
    [No Abstract]   [Full Text] [Related]  

  • 27. Limited echocardiography in the management of critically ill patients in shock.
    Sanfilippo F; Maybauer MO; Sankar V
    J Crit Care; 2015 Apr; 30(2):430. PubMed ID: 25573282
    [No Abstract]   [Full Text] [Related]  

  • 28. Catecholamine treatment for shock--equally good or bad?
    Singer M
    Lancet; 2007 Aug; 370(9588):636-7. PubMed ID: 17719998
    [No Abstract]   [Full Text] [Related]  

  • 29. Transient dobutamine-mediated pulsus alternans.
    Kahn JH; Starling MR; Supiano MA
    Can J Cardiol; 2001 Feb; 17(2):203-5. PubMed ID: 11223491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasopressor use in septic shock: an update.
    Leone M; Martin C
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):141-7. PubMed ID: 18443479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone.
    Nanas JN; Papazoglou PP; Terrovitis JV; Kanakakis J; Dalianis A; Tsolakis E; Tsagalou EP; Agrios N; Christodoulou K; Anastasiou-Nana MI
    Am J Cardiol; 2004 Nov; 94(10):1329-32. PubMed ID: 15541261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful reversal of resistent hypodynamic septic shock with levosimendan.
    Matejovic M; Krouzecky A; Radej J; Novak I
    Acta Anaesthesiol Scand; 2005 Jan; 49(1):127-8. PubMed ID: 15676005
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of intravenous positive inotropic therapy on myocardial damage in patients with dilated cardiomyopathy.
    Albayrak F; Demircan S; Yazici M; Arslandağ M
    Anadolu Kardiyol Derg; 2008 Feb; 8(1):69. PubMed ID: 18258539
    [No Abstract]   [Full Text] [Related]  

  • 34. Vasoactive drug support in septic shock.
    Dries DJ
    Shock; 2006 Nov; 26(5):529-30. PubMed ID: 17047528
    [No Abstract]   [Full Text] [Related]  

  • 35. Dobutamine to rescue the microcirculation?
    Spronk PE; Schultz MJ
    Crit Care Med; 2006 Oct; 34(10):2700; author reply 2700-1. PubMed ID: 16983282
    [No Abstract]   [Full Text] [Related]  

  • 36. Dobutamine stress echocardiography identifies anthracycline cardiotoxicity.
    Cottin Y; L'huillier I; Casasnovas O; Geoffroy C; Caillot D; Zeller M; Solary E; Guy H; Wolf JE
    Eur J Echocardiogr; 2000 Sep; 1(3):180-3. PubMed ID: 11916591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone.
    Nanas JN; Papazoglou P; Tsagalou EP; Ntalianis A; Tsolakis E; Terrovitis JV; Kanakakis J; Nanas SN; Alexopoulos GP; Anastasiou-Nana MI
    Am J Cardiol; 2005 Mar; 95(6):768-71. PubMed ID: 15757608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dobutamine compensates deleterious hemodynamic and metabolic effects of vasopressin in the splanchnic region in endotoxin shock.
    Martikainen TJ; Uusaro A; Tenhunen JJ; Ruokonen E
    Acta Anaesthesiol Scand; 2004 Sep; 48(8):935-43. PubMed ID: 15315609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between dobutamine response of dyssynergic myocardium and angiographically documented blood supply.
    Klaar U; Berger R; Gwechenberger M; Wutte M; Porenta G; Sochor H; Maurer G; Baumgartner H
    J Am Soc Echocardiogr; 2003 Sep; 16(9):949-57. PubMed ID: 12931107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
    Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC
    Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.